Gene Query: OAF

Dataset Description Geneva Score
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 111.32
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 111.32
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 91.86
Irf9 function in immunity in mouse 91.86
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 77.4
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 63.65
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 56.99
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 56.99
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 46.15
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 41.88
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 40.62
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 40.62
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 39.63
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 38.61
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 37.36
Statins modulate endothelial transcriptional profile by inhibiting EZH2 36.56
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 35.05
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 35.05
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 34.64
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 34.64
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 33.53
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 32.44
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 31.86
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 31.86
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 30.36
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 30.06
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 28.85
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 28.49
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 27.92
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 27.8
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 27.4
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 26.7
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 26.26
Effect of Hotair overexpression in human breast cancer cell lines 26.24
FOXP1 orchestration of ASD-relevant signaling pathways. 25.66
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 25.46
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 25.46
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 25.08
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 25.08
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 24.91
Hepatocyte maturation 24.5
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 24.4
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 24.32
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 24.24
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 24.08
RNA-seq of human fibroblasts after irradiation 23.94
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 23.78
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 23.77
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 23.74
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 23.67
RNA-seq analysis of AML cells in response to ASLAN003 22.86
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 22.8
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 22.31
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 22.17
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 22.17
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 21.99
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 21.94
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 21.83
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 21.76
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 21.69
Chromatin-informed inference of transcriptional programs in gynecologic cancers 21.69
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 21.09
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 21.06
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 21.01
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 21.0
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 20.82
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 20.82
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 20.44
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 20.15
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 20.15
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 20.07
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 19.82
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 19.64
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 19.61
Expression level comparison under dividing and quiescent states in human primary fibroblasts 19.51
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 19.48
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 19.24
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 19.18
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 19.1
MARS Seq data from human cortical organoids 18.99
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 18.6
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 18.6
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 18.41
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 18.18
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 18.14
RNA-seq of MCF10A cells and CAF 17.98
Spliceosomal disruption of the non-canonical BAF complex in cancer 17.83
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 17.76
SRSF2 mutations impair hematopoiesis and alter exon recognition 17.32
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 17.26
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 17.21
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 17.09
RNA-seq melanoma 16.96
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 16.79
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 16.62
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 16.57
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 16.44
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 16.43
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 16.26
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 16.25
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 16.05
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 15.93
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 15.84
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 15.62
BMS-470539 on human synovial fibroblasts 15.52
Global expression profiles in cardiac progenitor cells generated by ISX-9 15.48
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 15.48
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 15.37
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 15.23
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 15.12
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 15.08
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 14.93
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 14.82
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 14.77
Genome-wide chromatin analysis of Ewing sarcoma 14.77
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 14.67
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 14.65
TFAP2C signalling in human fibroblasts 14.54
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 14.32
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 14.21
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 14.21
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 14.2
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 14.2
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 14.15
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 13.95
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 13.95
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 13.79
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 13.73
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 13.68
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 13.68
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 13.38
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 13.38
DJ-1 is dispensable for human stem cell homeostasis 13.34
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 13.3
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  13.18
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 13.16
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 13.12
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 13.1
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 13.05
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 12.97
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 12.92
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 12.91
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 12.91
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 12.87
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 12.62
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 12.62
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 12.58
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 12.57
Lysine benzoylation is a novel histone mark 12.52
Lysine benzoylation is a novel histone mark [RNA-seq] 12.52
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 12.52
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 12.46
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 12.43
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 12.37
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 12.26
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 12.22
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 12.22
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 11.98
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 11.95
RNA-Seq analysis of breast cancer cells after shikonin treatment 11.89
11.77
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 11.75
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 11.75
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 11.61
Generation of trichogenic adipose-derived stem cells by expression of three factors 11.6
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 11.47
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 11.46
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 11.38
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 11.24
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 11.24
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 11.24
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 11.21
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 11.1
Peptidomimetic blockade of MYB in acute myeloid leukemia 11.1
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 10.94
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 10.91
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 10.85
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 10.78
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 10.78
STRIPAK directs PP2A activity to promote oncogenic transformation 10.68
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 10.63
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 10.53
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 10.53
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 10.49
RNA-seq of shEZH2 cells 10.46
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 10.45
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 10.42
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 10.33
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 10.31
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 10.28
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 10.22
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 10.22
snRNAs as regulators of alternative splicing 10.21
Gene expression changes in human melanoma cell lines compared to primary melanocytes 10.19
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  10.19
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 10.15
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 10.07
Differetially expressed genes after hTR overexpression in U2OS cells 10.06
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 10.06
Overexpression and knockdown experiment for circCSNK1G3 9.98
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 9.97
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 9.97
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 9.87
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 9.85
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 9.83
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 9.78
Subtle asymmetry of gene expression in embryonic and foetal human brains 9.73
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 9.67
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 9.6
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 9.52
Rorc disruption in human FG pancreatic cancer cells 9.41
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 9.34
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 9.34
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 9.32
An acquired vulnerability of drug resistant melanoma with therapeutic potential 9.29
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 9.29
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 9.25
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 9.23
DAOY-Notch1/Notch2 knockout: transcriptome comparison 9.21
9.14
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 9.12
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 9.06
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 9.03
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 9.02
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 9.0
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 8.98
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 8.98
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 8.98
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 8.89
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 8.89
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 8.88
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 8.84
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 8.8
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 8.69
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 8.62
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 8.58
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 8.56
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 8.51
RNA-Sequencing of HepG2 cells treated with TGFBeta 8.5
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 8.49
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 8.48
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 8.41
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 8.38
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 8.32
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 8.3
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 8.28
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 8.26
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 8.24
A practical evaluation of alignment algorithms for RNA variant calling analysis 8.22
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 8.17
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 8.17
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 8.16
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 8.14
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 7.98
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 7.95
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 7.95
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 7.94
Regulation of Lipids is Central to Replicative Senescence 7.9
Gene expression profile in breast cancer cell lines using RNA sequencing 7.89
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 7.89
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 7.87
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 7.85
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 7.83
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 7.8
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.76
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 7.76
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 7.72
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 7.69
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 7.65
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 7.59
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 7.51
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 7.46
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 7.44
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 7.44
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 7.42
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 7.42
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 7.35
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 7.28
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 7.25
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 7.25
Gene expression profiling of human and murine in vitro muscle differentiation 7.24
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 7.22
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 7.18
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 7.17
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 7.14
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 7.13
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 7.1
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 7.1
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 7.05
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 7.0
Efficient derivation of microglia-like cells from human pluripotent stem cells 6.98
Transcriptional responses of melanoma cells to BRAF inhibition 6.98
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 6.95
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 6.95
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.95
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 6.95
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 6.95
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 6.94
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 6.92
6mer seed toxicity in tumour suppressive microRNAs 6.89
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 6.81
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 6.75
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 6.75
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 6.74
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 6.7
Modeling Familial Cancer with iPSC Approaches 6.65
RNA-seq analysis of the human fetal kidney. 6.58
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 6.57
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 6.57
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 6.53
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 6.5
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 6.48
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 6.4
Gene expression analysis of human liver progenitor-like cells in culture 6.37
High-throughput sequencing of pluripotent cells 6.34
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 6.3
Endometrial transcriptome and PGR cistrome in cycling fertile women 6.29
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 6.29
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 6.19
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 6.12
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 6.11
Expression profiling of converted and control dermal BJ fibroblasts 6.06
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 6.06
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 5.96
CHD1 regulates cell fate determination by activation of differentiation-induced genes 5.96
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 5.93
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 5.92
EWS-Fli and LNC regulated genes in comparison to GFP samples 5.92
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 5.9
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 5.79
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 5.76
Transcriptional profiling of LS1034 cells treated with tepoxalin 5.74
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 5.48
Activity-dependent transcriptional changes in human neurons 5.42
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 5.42
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 5.38
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 5.38
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 5.32
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 5.31
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 5.31
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 5.31
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 5.31
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 5.19
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 5.13
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 5.09
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 5.01
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 4.95
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.91
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 4.87
Dermal endothelial cells of type 2 diabetic patients 4.86
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 4.85
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.83
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.83
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 4.83
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 4.8
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 4.8
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.76
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.68
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 4.67
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 4.65
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 4.65
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.59
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.59
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 4.58
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 4.58
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 4.54
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.52
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 4.42
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.41
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 4.39
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 4.39
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 4.39
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 4.37
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 4.23
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 4.15
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 4.15
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 4.11
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 4.11
Gene profiling of human adult and pediatric liver cancer cells 4.05
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 4.03
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 4.02
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 4.02
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 3.93
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 3.89
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 3.89
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 3.88
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 3.88
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 3.79
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 3.76
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 3.71
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 3.68
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 3.68
Patient-derived xenograft platform for metastatic melanoma 3.64
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.32
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 3.25
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.24
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 3.23
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 3.22
Functional Haploid Human Oocytes Generated from Polar Body Genomes 3.21
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 3.21
Postnatal lipids drive hepatocyte maturation 3.21
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 3.19
Metastasis in triple-negative breast cancer 3.19
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 3.12
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 3.08
Finding missing proteins from epigenetically manipulated human cells 3.07
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 3.07
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 3.07
circNFIB suppresses lymphatic metastasis of pancreatic cancer 3.05
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 3.01
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 2.99
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.97
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 2.89
Illumina Total RNA-seq in HeLa 2.89
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 2.85
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 2.84
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.82
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 2.81
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 2.8
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 2.77
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.73
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.7
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.7
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 2.65
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 2.44
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.43
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 2.38
Proteomics identifies a marker signature of MAPKi resistance in melanoma 2.26
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 2.24
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 2.21
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 2.08
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 2.04
The effect of Abl kinases on non-small cell carcinoma global transcriptome 2.01
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 2.01
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 2.0
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 1.94
Differential gene expression in Jagged1 treated human dental pulp cells. 1.83
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.83
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.81
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.76
Global epigenomic reconfiguration during mammalian brain development 1.76
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 1.72
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.72
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 1.69
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 1.63
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 1.63
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 1.6
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 1.6
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 1.58
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 1.54
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 1.53
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 1.51
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 1.51
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 1.51
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.44
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.43
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.43
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 1.35
KLF6-dependent transcription in renal cancer cells 1.34
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.34
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.31
Downregulation of LATS kinases alters p53 to promote cell migration 1.31
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 1.27
The role of the Calcium-Sensing receptor in colorectal cancer 1.18
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.12
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.12
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 1.08
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 1.08
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 1.04
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 1.01
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.0
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.98
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 0.95
Human islets of varying quality: the good, the (not so) bad and the ugly 0.92
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 0.75
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.71
Investigate A2M treatment on human prostate cancer and mouse liver 0.7
Investigate A2M treatment on human prostate cancer xenograft in mice 0.7
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.67
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.67
Gene expression profile of CRC-derived HILEC 0.6
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.59
hNSCs siRNA NOVA2 0.51
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.4
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 0.38
Loss of endometrial plasticity in recurrent pregnancy loss 0.33
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 0.33
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.29
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.26
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.19
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.19
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.19
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.15
Identification of Sin3B regulated genes during quiescence 0.14
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.1
RNA-Seq and expression data from human adipose tissue 0.1
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.09
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.09
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.05
Gene expression analysis of human adenomas. 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation